AAP Circumcision Task Force 1999
Jump to navigation Jump to search
This article is work in progress and not yet part of the free encyclopedia IntactiWiki.
Circumcision Policy Statement 1999
|“||Summary of Policy Statement 1999 |
Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy.
– AAP Task Force on Circumcision
Task Force on Circumcision 1999
Members of the Task Force on circumcision 1998-1999:
- Carole M. Lannon, M.D.[a 1], M.P.H.[a 2], Chairperson
- Ann Geryl Doll Bailey, M.D.[a 1]
- Alan R. Fleischman, M.D.[a 1]
- George W. Kaplan, M.D.[a 1]
- Craig T. Shoemaker, M.D.[a 1]
- Jack T. Swanson, M.D.[a 1]
- Donald Coustan, M.D.[a 1]
Doctor of Medicine, Wikipedia. Retrieved 14 June 2021.
Master of Public Health or Master of Philosophy in Public Health, Wikipedia. Retrieved 14 June 2021.